Cargando…

Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer

Acquired paclitaxel (PTX) resistance limits its effectiveness and results in advanced cancer progression. This review investigated whether the inhibition of phosphatidylinositol 3-kinase (PI3K) signaling overcomes paclitaxel resistance in cervical cancer. It was established paclitaxel-resistant cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing Jing, Ho, Jung Yoon, Lee, Hye Won, Baik, Min Wha, Kim, Oyoung, Choi, Youn Jin, Hur, Soo Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679163/
https://www.ncbi.nlm.nih.gov/pubmed/31295843
http://dx.doi.org/10.3390/ijms20143383
_version_ 1783441274753253376
author Liu, Jing Jing
Ho, Jung Yoon
Lee, Hye Won
Baik, Min Wha
Kim, Oyoung
Choi, Youn Jin
Hur, Soo Young
author_facet Liu, Jing Jing
Ho, Jung Yoon
Lee, Hye Won
Baik, Min Wha
Kim, Oyoung
Choi, Youn Jin
Hur, Soo Young
author_sort Liu, Jing Jing
collection PubMed
description Acquired paclitaxel (PTX) resistance limits its effectiveness and results in advanced cancer progression. This review investigated whether the inhibition of phosphatidylinositol 3-kinase (PI3K) signaling overcomes paclitaxel resistance in cervical cancer. It was established paclitaxel-resistant cell lines (PTX-R ME180/PTX-R HeLa) and determined the combination index for paclitaxel and PI3K inhibitors (BYL-719/ LY294002) by tetrazolium dye assay. Flow cytometry was used to detect the cell cycle and apoptosis. Migration and invasion were explored by wound healing and transwell assays. Genes related to multiple pathways were assessed by a western blot. It was found that the PI3K pathway was significantly activated in paclitaxel-resistant HeLa and ME180 cells compared to parental cells. PTX + PI3K inhibitor combined therapy showed a synergistic effect by strengthening paclitaxel-induced S and G(2)M arrest in PTX-R cell sublines by the inactivation of cyclin A1, cyclin B1, cyclin E, and Cdc2 expression. Moreover, combination therapy significantly enhanced drug sensitivity and apoptosis through the activation of Bax, and cleavage of poly-(ADP-ribose) polymerase compared with paclitaxel alone. In addition, PI3K inhibition also suppressed tumor migration and invasion by targeting β-catenin and matrix metalloproteinase-2/9. The authors suggest that the combination of a PI3K inhibitor with paclitaxel may enhance antitumor activity through a cascade of PI3K signaling events.
format Online
Article
Text
id pubmed-6679163
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66791632019-08-19 Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer Liu, Jing Jing Ho, Jung Yoon Lee, Hye Won Baik, Min Wha Kim, Oyoung Choi, Youn Jin Hur, Soo Young Int J Mol Sci Article Acquired paclitaxel (PTX) resistance limits its effectiveness and results in advanced cancer progression. This review investigated whether the inhibition of phosphatidylinositol 3-kinase (PI3K) signaling overcomes paclitaxel resistance in cervical cancer. It was established paclitaxel-resistant cell lines (PTX-R ME180/PTX-R HeLa) and determined the combination index for paclitaxel and PI3K inhibitors (BYL-719/ LY294002) by tetrazolium dye assay. Flow cytometry was used to detect the cell cycle and apoptosis. Migration and invasion were explored by wound healing and transwell assays. Genes related to multiple pathways were assessed by a western blot. It was found that the PI3K pathway was significantly activated in paclitaxel-resistant HeLa and ME180 cells compared to parental cells. PTX + PI3K inhibitor combined therapy showed a synergistic effect by strengthening paclitaxel-induced S and G(2)M arrest in PTX-R cell sublines by the inactivation of cyclin A1, cyclin B1, cyclin E, and Cdc2 expression. Moreover, combination therapy significantly enhanced drug sensitivity and apoptosis through the activation of Bax, and cleavage of poly-(ADP-ribose) polymerase compared with paclitaxel alone. In addition, PI3K inhibition also suppressed tumor migration and invasion by targeting β-catenin and matrix metalloproteinase-2/9. The authors suggest that the combination of a PI3K inhibitor with paclitaxel may enhance antitumor activity through a cascade of PI3K signaling events. MDPI 2019-07-10 /pmc/articles/PMC6679163/ /pubmed/31295843 http://dx.doi.org/10.3390/ijms20143383 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Liu, Jing Jing
Ho, Jung Yoon
Lee, Hye Won
Baik, Min Wha
Kim, Oyoung
Choi, Youn Jin
Hur, Soo Young
Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title_full Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title_fullStr Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title_full_unstemmed Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title_short Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer
title_sort inhibition of phosphatidylinositol 3-kinase (pi3k) signaling synergistically potentiates antitumor efficacy of paclitaxel and overcomes paclitaxel-mediated resistance in cervical cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679163/
https://www.ncbi.nlm.nih.gov/pubmed/31295843
http://dx.doi.org/10.3390/ijms20143383
work_keys_str_mv AT liujingjing inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT hojungyoon inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT leehyewon inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT baikminwha inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT kimoyoung inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT choiyounjin inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer
AT hursooyoung inhibitionofphosphatidylinositol3kinasepi3ksignalingsynergisticallypotentiatesantitumorefficacyofpaclitaxelandovercomespaclitaxelmediatedresistanceincervicalcancer